Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $29.0600 (0.62%) ($27.5000 - $29.2500) on Fri. Apr. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.21% (three month average) | RSI | 74 | Latest Price | $29.0600(0.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -2.1% a day on average for past five trading days. | Weekly Trend | IOVA advances 12.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(47%) XBI(46%) ARKG(45%) ARKK(41%) IWO(41%) | Factors Impacting IOVA price | IOVA will decline at least -4.105% in a week (0% probabilities). VIXM(-24%) UUP(-16%) VXX(-13%) TBT(-5%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.105% (StdDev 8.21%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
5 Day Moving Average | $29.15(-0.31%) | 10 Day Moving Average | $29.62(-1.89%) | 20 Day Moving Average | $27.49(5.71%) | To recent high | -25.2% | To recent low | 48.7% | Market Cap | $4.255b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |